Avid Bioservices Inc (CDMO)

[north40000]

I tend to agree the undervalued title might go to AMRN at the moment, but it is catching up fast. Interesting comparison between the 2---PPHM has to recover from the Fargo incident at the hands of its CRO employee[s], and AMRN must recover from the FDA adcom decision and the FDA rescinding, sua sponte, AMRN's SPA. At least AMRN's omega-3 capsule, Vascepa[96% EPA], is approved for a somewhat narrow indication, but can be prescribed off-label for others, accounting for the reason my physician prescribed it for me 2 years ago.